Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Source filing unavailable
| Metric | Q1 2015 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | — | $24.87K | — |
| Net Income | -$2.94M | -$2.87M | $3.00M |
| EPS Diluted | -$0.10 | -$0.33 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
